Weekly update Companies AI-cruiter Recruiting

Tenaya Therapeutics

Founded: 2016

Location: South SF, CA

Employee range: 50 - 200

Clinical stage: Clin1

Therapy area: Heart failure with preserved ejection fraction

Drug types: CVV, GEN

Lead product: TN-301

Product link: https://www.tenayatherapeutics.com/our-programs/#pipeline

Funding: $75M stock Nov 2022; $207M IPO Jul 2021; $106M C Mar 2021; $92M Oct 2019; $50M A Dec 2016

tenayatherapeutics.com

linkedin.com

job board

Short description:

Cardiovascular Therapeutics

Drug notes:

TN-201 Clin0 genetic hypertrophic cardiomyopathy (FT); TN-401 Clin0 genetic arrhythmogenic right ventricular cardiomyopathy; 4 undisclosed programs RD/Clin0 dilated cardiomyopathy, heart failures, genetic conditions, undisclosed

Long description:

Jobs:

Main

Contact: recruit@workinbiotech.com